Acadia Pharmaceuticals | ACAD - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 10.08 1.53 2026-03
ALKERMES 39.33 19.8 2026-03
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Biogen 13.7 0.32 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
Cara Therapeutics 27.77 117.09 2021-09
Corcept Therapeutics 113.58 71.67 2026-03
Eisai 35.61 8.98 2026-03
Eli Lilly 40.27 0.06 2026-03
Incyte 15.35 0.51 2026-03
J&J 24.53 0.91 2026-03
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 28.09 807.38 2026-03
Pfizer 9.32 5.16 2026-03
Prothena 22.11 11.37 2022-03
PTC Therapeutics 9.98 3.25 2025-12
Sarepta Therapeutics 27.27 0 2025-12
Vanda Pharmaceuticals 16.79 7.07 2023-06
Vertex Pharmaceuticals 25.82 0.33 2026-03